Achillion Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 56

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.06B

Achillion General Information

Description

Developer of innovative small-molecule drugs designed to transform the lives of patients and families affected by diseases of the complement system, an integral part of the innate immune system.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 121 Seaport Boulevard
  • Boston, MA 02210
  • United States
Primary Industry
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • 121 Seaport Boulevard
  • Boston, MA 02210
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Achillion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Merger/Acquisition 28-Jan-2020 $1.06B Completed Generating Revenue
15. Secondary Transaction - Open Market 31-Dec-2016 Completed Generating Revenue
14. 2PO 27-Feb-2013 Completed Clinical Trials - Phase 2
13. Secondary Transaction - Open Market 21-Sep-2012 Completed Clinical Trials - Phase 2
12. PIPE 30-Aug-2012 Completed Clinical Trials - Phase 2
11. 2PO 21-Jun-2011 Completed Clinical Trials - Phase 2
10. PIPE 23-Aug-2010 Completed Clinical Trials - Phase 2
9. Secondary Transaction - Open Market 31-Dec-2008 Completed Clinical Trials - Phase 2
8. PIPE 14-Aug-2008 $31.1M $188M Completed Clinical Trials - Phase 2
7. IPO 26-Oct-2006 $51.8M $156M Completed Clinical Trials - Phase 2
To view Achillion’s complete valuation and funding history, request access »

Achillion Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of innovative small-molecule drugs designed to transform the lives of patients and families affected by diseas
Drug Discovery
Boston, MA
56 As of 2018

Boston, MA
 

Pasadena, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Achillion Competitors (25)

One of Achillion’s 25 competitors is IFM Therapeutics, a Venture Capital-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
IFM Therapeutics Venture Capital-Backed Boston, MA
Meditope Biosciences Formerly VC-backed Pasadena, CA
Centrose Venture Capital-Backed Madison, WI
NGM Biopharmaceuticals Private Equity-Backed South San Francisco, CA
Sangamo Therapeutics Formerly VC-backed Richmond, CA
You’re viewing 5 of 25 competitors. Get the full list »

Achillion Patents

Achillion Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3193488-A1 Pharmaceutical compounds for the treatment of complement mediated disorders Pending 23-Sep-2020
EP-4216946-A1 Pharmaceutical compounds for the treatment of complement mediated disorders Pending 23-Sep-2020
EP-4216946-A4 Pharmaceutical compounds for the treatment of complement mediated disorders Pending 23-Sep-2020
US-20250171423-A1 Pharmaceutical compounds for the treatment of complement mediated disorders Pending 23-Sep-2020
WO-2022066774-A1 Pharmaceutical compounds for the treatment of complement mediated disorders Inactive 23-Sep-2020 C07D409/12
To view Achillion’s complete patent history, request access »

Achillion Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Achillion Former Investors (28)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advent International PE/Buyout Minority
Atlas Venture Venture Capital Minority
BB Biotech Asset Manager Minority
Bear Stearns Health InnoVentures Management Venture Capital Minority
Connecticut Innovations Venture Capital Minority
You’re viewing 5 of 28 investors. Get the full list »

Achillion ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Achillion’s complete esg history, request access »

Achillion FAQs

  • When was Achillion founded?

    Achillion was founded in 1998.

  • Where is Achillion headquartered?

    Achillion is headquartered in Boston, MA.

  • What is the size of Achillion?

    Achillion has 56 total employees.

  • What industry is Achillion in?

    Achillion’s primary industry is Drug Discovery.

  • Is Achillion a private or public company?

    Achillion is a Private company.

  • What is the current valuation of Achillion?

    The current valuation of Achillion is .

  • What is Achillion’s current revenue?

    The current revenue for Achillion is .

  • How much funding has Achillion raised over time?

    Achillion has raised $475M.

  • Who are Achillion’s investors?

    Advent International, Atlas Venture, BB Biotech, Bear Stearns Health InnoVentures Management, and Connecticut Innovations are 5 of 28 investors who have invested in Achillion.

  • Who are Achillion’s competitors?

    IFM Therapeutics, Meditope Biosciences, Centrose, NGM Biopharmaceuticals, and Sangamo Therapeutics are some of the 25 competitors of Achillion.

  • When was Achillion acquired?

    Achillion was acquired on 28-Jan-2020.

  • Who acquired Achillion?

    Achillion was acquired by Alexion.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process